Keyphrases
Acquired Demyelinating Syndromes
39%
Acute Disseminated Encephalomyelitis
21%
AMPA Receptor (AMPAR)
13%
Antibody-mediated
35%
Antibody-negative
12%
Aquaporin-4 (AQP4)
28%
Autistic Regression
10%
Autoantibodies
33%
Autoimmune
27%
Autoimmune Encephalitis
45%
Autoimmune Epilepsy
11%
Brain Networks
18%
CASPR2
25%
Central Nervous System
16%
Clinical Features
30%
Contactin-2
11%
Demyelinating Diseases
13%
Disease Course
21%
Disease-modifying Therapy
15%
Encephalitis
46%
Encephalopathy
15%
Epilepsy
26%
Epileptic Encephalopathy
38%
Epileptic Seizure
16%
Epileptiform Activity
12%
LGI1
28%
Limbic Encephalitis
10%
Magnetoencephalography
27%
MOG-Ab
25%
Mouse Model
11%
Multiple Sclerosis
23%
Myelin Oligodendrocyte Glycoprotein Antibody
18%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
19%
N-methyl-D-aspartate Receptor (NMDAR)
56%
N-methyl-D-aspartate Receptor Antibody
28%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
21%
Onconeural Antibodies
27%
Optic Neuritis
13%
Paraclinical
12%
Passive Transfer
11%
Pathogenic Antibodies
11%
Pediatric
77%
Pediatric Autoimmune Encephalitis
15%
Pediatric Epilepsy
12%
Pediatric multiple Sclerosis
11%
Rodent Models
11%
Seizure
56%
Surveillance Studies
15%
VGKC Antibody
12%
VGKC-complex
18%
Neuroscience
Acute Disseminated Encephalomyelitis
13%
AMPA Receptor
7%
Aquaporin 4 Antibody
11%
Aspartic Acid
37%
Autoantibodies
37%
Axonin 1
12%
Behavior (Neuroscience)
15%
Brain Disease
56%
Brain Network
20%
Central Nervous System
22%
Cognitive Disorders
8%
Contactin
31%
Decanoic Acid
7%
Demyelinating Disease
13%
Dextro Aspartic Acid
19%
Electroencephalography
13%
Encephalitis
77%
Epileptic Seizure
8%
Expanded Disability Status Scale
11%
Focal Epilepsy
9%
GRIN2A
7%
Ictal
11%
Immune System Disorders
9%
Immunotherapy
45%
In Vitro
27%
In Vivo
33%
Intravenous Immunoglobulin
8%
Leucine
24%
Limbic Encephalitis
11%
Magnetic Resonance Imaging
14%
Magnetic Resonance Imaging of Brain
8%
Magnetoencephalography
27%
Multiple Sclerosis
25%
Myelin Oligodendrocyte Glycoprotein
39%
N Methyl Dextro Aspartic Acid Receptor Antibody
7%
Nerve Fiber
7%
Nervous System Disorder
11%
Neurological Disorder
9%
Neuromyelitis Optica
12%
Neurophysiology
9%
Neurosteroid
10%
Optic Neuritis
13%
Pediatric Epilepsy
15%
Perampanel
7%
Receptor
37%
Receptor Antibody
38%
Relapsing Remitting Multiple Sclerosis
7%
Stereotypic Movement Disorder
10%
Synaptic Transmission
13%
Voltage-Gated Potassium Channel
12%
Medicine and Dentistry
Acute Disseminated Encephalomyelitis
21%
Allergic Encephalitis
21%
AMPA Receptor
7%
Aquaporin 4 Antibody
26%
Autoantibodies
16%
Autoantigen
7%
Basal Ganglia
7%
Brain Disease
41%
Brain Tissue
7%
Central Nervous System
14%
Clinical Feature
21%
Clinically Isolated Syndrome
8%
Contactin
12%
Decanoic Acid
7%
Dextro Aspartic Acid
12%
Disease
25%
Disease Course
20%
Disease Modifying Therapy
7%
Encephalitis
14%
Epilepsy
9%
Epileptic Seizure
32%
Epileptiform Activity
7%
Ganglioglioma
11%
GRIN2A
7%
Immunotherapy
24%
In Vitro
9%
Leucine
11%
Magnetic Resonance Imaging
18%
Magnetic Resonance Imaging of Brain
7%
Magnetoencephalography
19%
MOG Antibody Disease
7%
Multiple Sclerosis
37%
Myelin Oligodendrocyte Glycoprotein
16%
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
18%
Myokymia
7%
N Methyl-D-Aspartate Receptor
11%
Neurologic Disease
9%
Neuromyelitis Optica
12%
Onset Age
8%
Paraneoplastic Cerebellar Degeneration
11%
Partial Seizure
10%
Pediatric Neurology
10%
Pediatrics
100%
Perampanel
7%
Psychological Outcome
7%
Receptor Antibody
18%
Recurrent Disease
9%
Synapsin I
7%
Transverse Myelitis
10%
Voltage-Gated Potassium Channel
10%